
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings is facing a temporary setback with lower than expected revenue from its EOS imaging business in the recent quarter, which has prompted a reduction in full-year revenue guidance. This was a result of execution issues and missed hardware sales, leading to a decrease in contribution from EOS. However, the company remains profitable with adjusted EBITDA guidance of $134M and FCF guidance of $20M for 2026. The adjusted operating margin was up 630 bps Y/Y and beat consensus, showcasing the company's ability to drive meaningful OpEx leverage and improve asset efficiency. Despite the EOS growth slowdown, the fundamentals of the business remain strong and management has taken steps to address the execution issues, with expectations for improvement in the second half of 2026. The company's core surgical business is still expected to deliver $805M in sales, supporting the positive outlook for long-term growth potential.
Bears say
Alphatec Holdings is facing challenges with its recent Q1 results and revised sales guidance, driven by weaker-than-expected EOS sales and unfavorable surgical case mix. While the company has a strong portfolio of products and growth potential in the long-term, poor sales execution, an increasingly competitive market, and a potential dilutive equity offering or acquisitions may hinder its profitability. Despite initial progress in addressing issues, the stock price has dropped significantly and the outlook remains negative due to these challenges.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares